31 Mar 2020
Assets5,073.29
Total Income5,975.65
Profit After Tax1,056.15
NET Worth3,485.31
Reserves and Surplus3,436.34
Total Borrowing126.92
At a glance
Updated 2026-08-23The shares listed at ₹1,300.00, a 20.37% move from the issue price. Mankind Pharma is a Mainboard IPO with an issue size of ₹4,326.36 crore, proposed for listing on BSE, NSE. The offer opens on 25th Apr 2023 and closes on 27th Apr 2023. The issue structure includes an offer-for-sale component of ₹4,326.36 crore. The current listing schedule points to 9th May 2023.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹4,326.36 Cr
Offer for sale₹4,326.36 Cr
Face value₹1
Price band₹1,026.00–₹1,080.00
Allotment3rd May 2023
Listing9th May 2023
Listing performance
Full performance ↗Issue price₹1,080.00
Listing price₹1,300.00
Current price—
Listing gain20.37%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹121.00
GMP / upper price11.20%
Est. listing₹1,201.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens25th Apr 2023
Closes27th Apr 2023
Allotment3rd May 2023
Refund4th May 2023
Demat5th May 2023
Listing9th May 2023
Subscription demand
Full bidding ↗Total15.32×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 13 | ₹14,040 |
Company
Incorporated1991
Use of proceeds
| Object | Amount |
|---|---|
| Carry out the Offer for Sale of 40,058,844Equity Shares by the Selling Shareholders aggregating to ₹43,263.55 million | — |
| Achieve the benefits of listing the Equity Shares on the Stock Exchanges. For further details | — |
Financials
Full financials ↗31 Mar 2021
Assets6,372.63
Total Income6,385.38
Profit After Tax1,293.03
NET Worth4,722.00
Reserves and Surplus4,674.39
Total Borrowing234.53
31 Dec 2021
Assets8,043.88
Total Income6,218.29
Profit After Tax1,260.24
NET Worth5,965.46
Reserves and Surplus5,916.86
Total Borrowing268.70
31 Mar 2022
Assets9,147.74
Total Income7,977.58
Profit After Tax1,452.96
NET Worth6,155.23
Reserves and Surplus6,106.06
Total Borrowing868.03
31 Dec 2022
Assets9,273.75
Total Income6,777.82
Profit After Tax1,015.98
NET Worth7,145.89
Reserves and Surplus7,094.12
Total Borrowing167.93
Trend chart₹ crore
KPIs
| KPI |
|---|
| ROE |
| ROCE |
| RoNW |
| PAT Margin |
Valuation & shareholding
Pre-IPO EPS33.20
Pre-IPO P/E32.5
Promoter holding pre79%
Promoter holding post76.5%
Market cap₹43263.60 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Fees payable to the BRLMs and commissions(including underwriting commission, brokerage and selling commission) | ₹102.23 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank and Banker to the Offer andBidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹0.85 Cr |
| Fees payable to the Registrar to the Offer | ₹1.28 Cr |
| Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and otherregulatory expenses | ₹10.74 Cr |
| Advertising and marketing expenses | ₹13.12 Cr |
| Printing and distribution of Offer related stationery | ₹3.14 Cr |
| Fees payableto legal counsel; and | ₹10.62 Cr |
| Fees payable to other parties, including but not limited toauditors, independentchartered accountant, industryexpert, intellectual property consultant, independent chartered engineer and ROC consultant | ₹20.61 Cr |
| Miscellaneous | ₹9.05 Cr |
Registrar & lead managers
Registrar
Kfin Technologies Ltd.Lead managers
- Kotak Mahindra Capital Co.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.